Policy reform and the international future of Moroccan Cannabis production.
Study Design
- Study Type
- Other
- Population
- None
- Intervention
- Policy reform and the international future of Moroccan Cannabis production. None
- Comparator
- None
- Primary Outcome
- None
- Effect Direction
- Mixed
- Risk of Bias
- Unclear
Abstract
In 2023, Morocco produced the first legal Cannabis crop of any illegal hashish-producing country, only three years after it legalised the cultivation of Cannabis for medical and industrial purposes. Nevertheless, as the country continues to amend its regulatory framework and economic policies, numerous questions and uncertainties persist regarding the success of its strategy for the export of Cannabis products and the evolution of its domestic consumer market. This current study details and explains how Morocco has advantageously legalised what it calls "licit uses of cannabis", notably by not referring to hemp, but also by making the strategic decision not to adopt an overall tetrahydrocannabinol (THC) threshold. This study also addresses key agricultural technicalities, such as how higher legal THC levels benefit cannabidiol (CBD) yields and how this directly impacts economic competitiveness, as well as how legal rules and details are structuring a new and rapidly changing global legal cannabinoid market. This study goes beyond the case of Morocco by considering what diverse and evolving international legislations mean for potential future Moroccan exports, depending on how CBD is viewed and regulated in different countries, whether as a pharmaceutical, a wellness product, or a food supplement. The study concludes that while the Moroccan authorities have quickly and pragmatically adapted their regulations, both at the production and consumption level, the future of Morocco's legal Cannabis industry remains largely dependent on local and global environmental and economic factors that will influence its development and viability.
Used In Evidence Reviews
Similar Papers
Current psychiatry reports · 2017
Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
Archives of internal medicine · 2007
Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials.
Pharmaceuticals (Basel, Switzerland) · 2012
Cannabidiol in humans-the quest for therapeutic targets.
Nutricion hospitalaria · 2015
NUTRITIONAL AND TOXICOLOGICAL ASPECTS OF SPIRULINA (ARTHROSPIRA).
CNS drugs · 2022
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
The Permanente journal · 2016